Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
Authors
Keywords
-
Journal
Cell Reports
Volume 37, Issue 13, Pages 110169
Publisher
Elsevier BV
Online
2021-12-07
DOI
10.1016/j.celrep.2021.110169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
- (2021) Aurélien Sokal et al. CELL
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
- (2021) Martin Dugas et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
- (2021) Matthias Becker et al. Nature Communications
- A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
- (2021) Alexandra Tauzin et al. Cell Host & Microbe
- Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
- (2021) Martin Dugas et al. JOURNAL OF CLINICAL VIROLOGY
- Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
- (2021) Lucie Loyal et al. SCIENCE
- Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
- (2021) Natalia Ortega et al. Nature Communications
- Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
- (2021) Youssif M. Ali et al. Frontiers in Immunology
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- Epidemiology and Clinical Symptoms Related to Seasonal Coronavirus Identified in Patients with Acute Respiratory Infections Consulting in Primary Care over Six Influenza Seasons (2014–2020) in France
- (2020) Shirley Masse et al. Viruses-Basel
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
- (2020) Petra Bacher et al. IMMUNITY
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Human coronavirus circulation in the United States 2014–2017
- (2018) Marie E. Killerby et al. JOURNAL OF CLINICAL VIROLOGY
- Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population
- (2008) E. G. Severance et al. Clinical and Vaccine Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search